{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T22:59:58Z","timestamp":1791500398280,"version":"4.3.4"},"reference-count":45,"publisher":"Public Library of Science (PLoS)","issue":"10","license":[{"start":{"date-parts":[[2009,10,30]],"date-time":"2009-10-30T00:00:00Z","timestamp":1256860800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0007661","type":"journal-article","created":{"date-parts":[[2009,10,29]],"date-time":"2009-10-29T21:33:03Z","timestamp":1256851983000},"page":"e7661","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":32,"title":["Reciprocal t(9;22) ABL\/BCR Fusion Proteins: Leukemogenic Potential and Effects on B Cell Commitment"],"prefix":"10.1371","volume":"4","author":[{"given":"Xiaomin","family":"Zheng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia","family":"Oancea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reinhard","family":"Henschler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Malcolm A. S.","family":"Moore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Ruthardt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2009,10,30]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1056\/NEJM199907153410306","article-title":"The biology of chronic myeloid leukemia.","volume":"341","author":"S Faderl","year":"1999","journal-title":"N Engl J Med"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1038\/nrc2147","article-title":"Chronic myeloid leukaemia as a model of disease evolution in human cancer.","volume":"7","author":"JV Melo","year":"2007","journal-title":"Nat Rev Cancer"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1182\/asheducation-2007.1.384","article-title":"The Biology of CML Blast Crisis.","author":"JP Radich","year":"2007","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1182\/asheducation-2006.1.133","article-title":"Treatment of adult acute lymphoblastic leukemia.","author":"N G\u00f6kbuget","year":"2006","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1159\/000065655","article-title":"Cytogenetic and molecular genetic aspects of chronic myeloid leukaemia.","volume":"108","author":"DJ Barnes","year":"2002","journal-title":"Acta Haematol"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1182\/blood.V81.1.158.158","article-title":"The ABL-BCR fusion gene is expressed in chronic myeloid leukemia.","volume":"81","author":"JV Melo","year":"1993","journal-title":"Blood"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"2488","DOI":"10.1182\/blood.V81.10.2488.2488","article-title":"Expression of the ABL-BCR fusion gene in Philadelphia-positive acute lymphoblastic leukemia.","volume":"81","author":"JV Melo","year":"1993","journal-title":"Blood"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"2862","DOI":"10.4161\/cc.5.24.3573","article-title":"Primitive, quiescent and difficult to kill: the role of non-proliferating stem cells in chronic myeloid leukemia.","volume":"5","author":"DJ Barnes","year":"2006","journal-title":"Cell Cycle"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"2542","DOI":"10.1056\/NEJMoa055104","article-title":"Nilotinib in imatinib-resistant CML and Philadelphia chromosome-positive ALL.","volume":"354","author":"H Kantarjian","year":"2006","journal-title":"N Engl J Med"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"5790","DOI":"10.1158\/0008-5472.CAN-05-4187","article-title":"The structure of Dasatinib (BMS-354825) bound to activated ABL kinase domain elucidates its inhibitory activity against imatinib-resistant ABL mutants.","volume":"66","author":"J Tokarski","year":"2006","journal-title":"Cancer Res"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1186\/1471-2407-6-262","article-title":"BCR and its mutants, the reciprocal t(9;22)-associated ABL\/BCR fusion proteins, differentially regulate the cytoskeleton and cell motility.","volume":"6","author":"X Zheng","year":"2006","journal-title":"BMC Cancer"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"4663","DOI":"10.1128\/MCB.23.13.4663-4672.2003","article-title":"The Bcr kinase down-regulates Ras signaling by phosphorylating AF-6 and binding to its PDZ domain.","volume":"23","author":"G Radziwill","year":"2003","journal-title":"Mol Cell Biol"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1016\/j.febslet.2006.01.034","article-title":"Bcr interferes with beta-catenin-Tcf1 interaction.","volume":"580","author":"A Ress","year":"2006","journal-title":"FEBS Lett"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"2295","DOI":"10.1101\/gad.11.18.2295","article-title":"Rho GTPases and signaling networks.","volume":"11","author":"LV Aelst","year":"1997","journal-title":"Genes Dev"},{"key":"ref15","first-page":"F1","article-title":"Dbl family proteins.","volume":"1332","author":"I Whitehead","year":"1997","journal-title":"Biochim Biophys Acta"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"3535","DOI":"10.1182\/blood-2003-09-3335","article-title":"Gamma-catenin contributes to leukemogenesis induced by AML-associated translocation products by increasing the self-renewal of very primitive progenitor cells.","volume":"103","author":"X Zheng","year":"2004","journal-title":"Blood"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"4226","DOI":"10.1093\/emboj\/16.14.4226","article-title":"Immortalization and leukemic transformation of a myelomonocytic precursor by retrovirally transduced HRX-ENL.","volume":"16","author":"C Lavau","year":"1997","journal-title":"EMBO J"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"3229","DOI":"10.1182\/blood-2002-05-1515","article-title":"Prenatal and postnatal myeloid cells demonstrate stepwise progression in the pathogenesis of MLL fusion gene leukemia.","volume":"101","author":"JJ Johnson","year":"2003","journal-title":"Blood"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/j.cell.2008.01.025","article-title":"Hematopoiesis: an evolving paradigm for stem cell biology.","volume":"132","author":"SH Orkin","year":"2008","journal-title":"Cell"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1038\/sj.leu.2403367","article-title":"Acute promyelocytic leukemia: PML\/RARalpha and the leukemic stem cell.","volume":"18","author":"E Puccetti","year":"2004","journal-title":"Leukemia"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1182\/blood.V100.1.238","article-title":"Bethesda proposals for classification of nonlymphoid hematopoietic neoplasms in mice.","volume":"100","author":"SC Kogan","year":"2002","journal-title":"Blood"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1084\/jem.20062662","article-title":"Activation-induced cytidine deaminase acts as a mutator in BCR-ABL1-transformed acute lymphoblastic leukemia cells.","volume":"204","author":"N Feldhahn","year":"2007","journal-title":"J Exp Med"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1038\/sj.leu.2401004","article-title":"Culture system for extensive production of CD19+IgM+ cells by human cord blood CD34+ progenitors.","volume":"12","author":"JI Ohkawara","year":"1998","journal-title":"Leukemia"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1038\/ni1454","article-title":"Pax5: the guardian of B cell identity and function.","volume":"8","author":"C Cobaleda","year":"2007","journal-title":"Nat Immunol"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.coi.2006.01.007","article-title":"Transcription factors drive B cell development.","volume":"18","author":"J Hagman","year":"2006","journal-title":"Curr Opin Immunol"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1084\/jem.20030802","article-title":"The balance between Pax5 and Id2 activities is the key to AID gene expression.","volume":"198","author":"H Gonda","year":"2003","journal-title":"J Exp Med"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1038\/ni1285","article-title":"Intrinsic inhibition of transcription factor E2A by HLH proteins ABF-1 and Id2 mediates reprogramming of neoplastic B cells in Hodgkin lymphoma.","volume":"7","author":"S Mathas","year":"2006","journal-title":"Nat Immunol"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1146\/annurev.immunol.23.021704.115606","article-title":"Cell signaling and tumorigenesis.","volume":"23","author":"H Jumaa","year":"2005","journal-title":"Annu Rev Immunol"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/S1074-7613(00)80591-9","article-title":"BLNK: a central linker protein in B cell activation.","volume":"9","author":"C Fu","year":"1998","journal-title":"Immunity"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"14931","DOI":"10.1073\/pnas.0607006103","article-title":"The age incidence of chronic myeloid leukemia can be explained by a one-mutation model.","volume":"103","author":"F Michor","year":"2006","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1073\/pnas.97.4.1737","article-title":"Regulated expression of P210 Bcr-Abl during embryonic stem cell differentiation stimulates multipotential progenitor expansion and myeloid cell fate.","volume":"97","author":"T Era","year":"2000","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/j.ccr.2004.10.015","article-title":"MOZ-TIF2, but not BCR-ABL confers properties of leukemic stem cells to committed murine hematopoietic progenitors.","volume":"6","author":"BJP Huntly","year":"2004","journal-title":"Cancer Cell"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"2747","DOI":"10.1101\/gad.313104","article-title":"c-Myc controls the balance between hematopoietic stem cell self-renewal and differentiation.","volume":"18","author":"A Wilson","year":"2004","journal-title":"Genes Dev"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"4075","DOI":"10.1093\/emboj\/17.14.4075","article-title":"Activation of RhoA and SAPK\/JNK signalling pathways by the RhoA-specific exchange factor mNET1.","volume":"17","author":"AS Alberts","year":"1998","journal-title":"EMBO J"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"6082","DOI":"10.1128\/MCB.02202-05","article-title":"Kinase domain mutants of Bcr-Abl exhibit altered transformation potency, kinase activity, and substrate utilization, irrespective of sensitivity to imatinib.","volume":"26","author":"IJ Griswold","year":"2006","journal-title":"Mol Cell Biol"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"2744","DOI":"10.1002\/ijc.23467","article-title":"Targeting of the N-terminal coiled coil oligomerization interface by a helix-2 peptide inhibits unmutated and imatinib-resistant BCR\/ABL.","volume":"122","author":"T Beissert","year":"2008","journal-title":"Int J Cancer"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1111\/j.1365-2141.1995.tb08361.x","article-title":"Interferon response in chronic myeloid leukaemia correlates with ABL\/BCR expression: a preliminary study.","volume":"89","author":"JL Yin","year":"1995","journal-title":"Br J Haematol"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"1732","DOI":"10.1182\/blood.V98.6.1732","article-title":"Deletions of the derivative chromosome 9 occur at the time of the Philadelphia translocation and provide a powerful and independent prognostic indicator in chronic myeloid leukemia.","volume":"98","author":"BJ Huntly","year":"2001","journal-title":"Blood"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"2879","DOI":"10.1182\/blood.V98.9.2879","article-title":"ABL-BCR expression does not correlate with deletions on the derivative chromosome 9 or survival in chronic myeloid leukemia.","volume":"98","author":"J de la Fuente","year":"2001","journal-title":"Blood"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1182\/blood-2007-02-074252","article-title":"Heterogeneous prognostic impact of derivative chromosome 9 deletions in chronic myelogenous leukemia.","volume":"110","author":"S Kreil","year":"2007","journal-title":"Blood"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1084\/jem.20031637","article-title":"The BCR-ABL1 kinase bypasses selection for the expression of a pre-B cell receptor in pre-B acute lymphoblastic leukemia cells.","volume":"199","author":"F Klein","year":"2004","journal-title":"J Exp Med"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1038\/344251a0","article-title":"Acute leukaemia in bcr\/abl transgenic mice.","volume":"344","author":"N Heisterkamp","year":"1990","journal-title":"Nature"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1038\/71691","article-title":"Reversibility of acute B-cell leukaemia induced by BCR-ABL1.","volume":"24","author":"CS Huettner","year":"2000","journal-title":"Nat Genet"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"8643","DOI":"10.1038\/sj.onc.1206091","article-title":"Studying the pathogenesis of BCR-ABL+ leukemia in mice.","volume":"21","author":"RAV Etten","year":"2002","journal-title":"Oncogene"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"2537","DOI":"10.1158\/0008-5472.CAN-04-3011","article-title":"Valproic acid stimulates proliferation and self-renewal of hematopoietic stem cells.","volume":"65","author":"G Bug","year":"2005","journal-title":"Cancer Res"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0007661","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,23]],"date-time":"2020-05-23T09:45:11Z","timestamp":1590227111000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0007661"}},"subtitle":[],"editor":[{"given":"Catherine M.","family":"Verfaillie","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2009,10,30]]},"references-count":45,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2009,10,30]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0007661","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,10,30]]}}}